期刊
LEUKEMIA
卷 34, 期 10, 页码 2592-2606出版社
SPRINGERNATURE
DOI: 10.1038/s41375-020-0990-y
关键词
-
资金
- MEXT, Japan (KAKENHI) [19H03684]
- AMED, Japan [cm0106505h, lm0203097h]
- Grants-in-Aid for Scientific Research [19H03684] Funding Source: KAKEN
It has been nearly half a century since angioimmunoblastic T-cell lymphoma (AITL) was characterized in the early 1970's. Our understanding of the disease has dramatically changed due to multiple discoveries and insights. One of the key features of AITL is aberrant immune activity. Although AITL is now understood to be a neoplastic disease, pathologists appreciated that it was an inflammatory condition. The more we understand AITL at cellular and genetic levels, the more we view it as both a neoplastic and an inflammatory disease. Here, we review recent progress in our understanding of AITL, focusing on as yet unsolved questions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据